Approval · Notice of Compliance 15822 · 2014
JAMP-VANCOMYCIN: Notice of Compliance 15822
Issued July 14, 2014
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 15822
- Date
- July 14, 2014
- Company
- JAMP Pharma CorporationBoucherville, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to an Abbreviated New Drug Submission (SANDS), supplement
- Submission class
- Admin
- Reason
- Change in manufacturing process, addition of manufacturing site involving testing of api, addition of drug product manufacturing site, addition of supplier of container closure system, change in the composition of a solution dosage form
- Therapeutic class
- Antibiotic
- Canadian reference product
- VANCOMYCIN HYDROCHLORIDE FOR INJECTION USP (Pharmaceutical Partners Of Canada Inc)
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| JAMP-VANCOMYCIN | Not yet assigned | — |
Medicinal ingredients
- VANCOMYCIN HYDROCHLORIDE 500 MG per VIAL
- VANCOMYCIN HYDROCHLORIDE 1 G per VIAL
- VANCOMYCIN HYDROCHLORIDE 5 G per VIAL
- VANCOMYCIN HYDROCHLORIDE 10 G per VIAL